• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Latest News about Novo Nordisk A/S

    Recent news which mentions Novo Nordisk A/S

    < Previous 1 2
    ...
    4 5 6 7 8 9 10 11 Next >
    Older GLP-1 drug from Novo Nordisk may slow Alzheimer's disease progression by protecting the brain, study says
    Tags Breaking News: Business Business Health care industry
    From CNBC.com News
    Swiss pharma giant Roche to accelerate Wegovy rival drugs after positive trial data
    Tags Eli Lilly and Co Business Business News
    From CNBC.com News
    Viking Therapeutics stock jumps 16% after drugmaker moves weight loss injection to late-stage trial
    Tags Biotechnology Novo Nordisk A/S Viking Therapeutics Inc
    From CNBC.com News
    Wegovy rival to be part of a suite of weight loss drugs, Roche CEO says following positive trial results
    Tags Biotech and Pharmaceuticals Pharmaceuticals Novo Nordisk A/S
    From CNBC.com News
    Healthy Returns: The first round of Medicare drug price negotiations is nearing an end
    Tags Bristol/Myers Squibb Co Johnson & Johnson Health care industry
    From CNBC.com News
    Novo Nordisk's Wegovy weight loss drug wins UK approval for use as a heart treatment
    Tags Health & Science Pharmaceuticals Health care industry
    From CNBC.com News
    Novo Nordisk and Eli Lilly shares slide on new obesity drug trial from Roche
    Tags Pharmaceuticals Breaking News: Markets Novo Nordisk A/S
    From CNBC.com News
    Healthy Returns: Diabetes drug Ozempic may lower dementia risk, nicotine use
    Tags Merck & Co Inc Novo Nordisk A/S Science
    From CNBC.com News
    Healthy Returns: Drugmakers are racing to develop more convenient weight loss pills
    Tags Healthy Returns Health & Science Health care industry
    From CNBC.com News
    Pfizer moves forward with once-daily version of weight loss pill after setbacks
    Tags Biotechnology Novo Nordisk A/S Pharmaceuticals
    From CNBC.com News
    Jim Cramer on Hims & Hers Health stock: 'I bet the business stays strong'
    Tags Hims & Hers Health Inc Business Stock markets
    From CNBC.com News
    FTC to sue drug middlemen over prices of medications including insulin
    Tags UnitedHealth Group Inc Business News Health care industry
    From CNBC.com News
    CNBC Daily Open: French left-wing shock victory, Boeing guilty plea
    Tickers LAWS
    Tags Europe Politics Market Outlook Economic policy
    From CNBC.com News
    CNBC Daily Open: French far-right advance blocked
    Tags Interest Rates Tesla Inc Goldman Sachs Group Inc
    From CNBC.com News
    This ETF is trying to satisfy appetites for weight loss stocks
    Tags Personal investing Stock markets Mondelez International Inc
    From CNBC.com News
    Novo Nordisk shares shrug off concerns over study linking weight loss drugs to rare eye condition
    Tags Biotechnology Novo Nordisk A/S Science
    From CNBC.com News
    Healthy Returns: Brain implant company Paradromics launches patient registry ahead of human trial
    Tags Eli Lilly and Co Health & Science Viking Therapeutics Inc
    From CNBC.com News
    Healthy Returns: Eli Lilly, other drugmakers show off encouraging weight loss drug data
    Tags Oracle Corp Altimmune Inc Health care industry
    From CNBC.com News
    5 things to know before the stock market opens
    Tags Novo Nordisk A/S Nasdaq Inc Politics
    From CNBC.com News
    Novo Nordisk's Wegovy weight loss drug approved in China
    Tags Business Biotech and Pharmaceuticals Asia News
    From CNBC.com News
    Novo Nordisk to build $4.1 billion North Carolina facility to boost output of Wegovy, Ozempic
    Tags Business News Health care industry Biotech and Pharmaceuticals
    From CNBC.com News
    Weight loss drug contender Zealand Pharma jumps 23% on trial results
    Tags Zealand Pharma A/S Novo Nordisk A/S Europe Markets
    From CNBC.com News
    Healthy Returns: More U.S. employers are now covering GLP-1s for weight loss
    Tags Labor economy Biotech and Pharmaceuticals Health care industry
    From CNBC.com News
    How Eli Lilly is managing soaring demand for GLP-1s, according to outgoing CFO Anat Ashkenazi
    Tags CNBC Changemakers US: News Companies
    From CNBC.com News
    European stocks set for muted open after European Central Bank cut
    Tags World Markets World Economy World economy
    From CNBC.com News
    Why half of all workers may struggle to get weight-loss drug health insurance coverage
    Tags Personal finance Small Business: Management Personnel
    From CNBC.com News
    Telehealth company Ro launches GLP-1 supply tracker to help patients navigate shortages
    Tags Breaking news Biotech and Pharmaceuticals Health care industry
    From CNBC.com News
    Cramer's Lightning Round: Apple is a buy
    Tags Apple Inc Stock Picks Investment Strategy
    From CNBC.com News
    This new weight loss drug ETF bets big on two of the industry's leading players
    Tags Personal investing NVIDIA Corp Stock markets
    From CNBC.com News
    How digital health companies are capitalizing on the GLP-1 boom
    Tags Internet Technology Novo Nordisk A/S
    From CNBC.com News
    < Previous 1 2
    ...
    4 5 6 7 8 9 10 11 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.